The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
EPITA, the European Pancreas and Islet Transplant Association, wishes to announce a call for nominations for a new Board member. The mandate of the new EPITA Board Member is 4 years (2021-2025). Given the current composition of the EPITA Board, and to ensure that all relevant specialties are represented, applications from diabetes (transplant) physicians will be
Help spread the word about 20th edition of the congress taking place in Milan (from 29th August to 1st September)! Use our tools and resources to promote the #ESOTcongress to your networks. Visit www.esotcongress for more information
ESOT recognises the importance of value-based care as an essential part of delivering improved treatment for transplant patients and is committed to working alongside patient representatives to help shape equitable, sustainable, and appropriate learning resources that address the needs of the patient community. Our value-based care domain is led by leading experts in the field
In July 2020, Transplant International published a letter to the editors by Anna Forsberg (ETAHP) and Emma Massey (ELPAT) on the impact of the COVID-19 pandemic on transplant patients. In this paper, following the webinar “Coping with uncertainty during the COVID-19 pandemic”, organised by ESOT and held on April 27, 2020, the two authors address
We are delighted to announce that our Sections & Committees have opened a number of opportunities to join the boards: ECTORS | ECTTA | EDTCO | EKITA | ELITA |EPITA| VCA | BSC | ETAHP | YPT We encourage you to get involved in your preferred Section/Committee by submitting your nominations and exercising your right to vote! Read more
We would like to announce a call for nominations for six new Board members. The new YPT Board members will hold office for 4 years (2021-2025), effective from the ESOT Congress 2021. The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who
We would like to announce a call for nominations for four new Board members. ESOT/VCA affiliates are eligible to submit their application for the positions. The intention of the ESOT VCA Section is to foster the scientific and clinical development of Vascularized Composite Allotransplantation in Europe and to serve as a platform for scientists and
We would like to announce a call for nominations for two new Board members. ESOT/EDTCO affiliates active within the field of organ, tissue and cell donation for transplantation are eligible to submit their application for the positions, or to present another EDTCO affiliate as candidate. Applications from intensivists and donation coordinators will be given preferential
We would like to announce a call for nominations for two new Board members. ETAHP is the ESOT Committee representing European nurses and allied healthcare professionals who wish to promote evidence-based transplant care in order to improve health and well-being of organ transplant candidates and recipients. ETAHP includes patients in our activities, to give them
We would like to announce a call for nominations for two new Board members. All ESOT/Basic Science Committee affiliates are eligible to submit their application for the positions. Applications from PhDs with some years of postdoc experience and researchers with a strong basic science background will be given preferential consideration. The Board reserves the right
